Forward Pharma A/S (FWP) |
|---|
| $14.89 52 Week Low | $19.73 2017-04-28 14:17:17 MDT | $33 52 Week High |
| Healthcare Sector | Biotechnology Industry |
| Nasdaq Stock Exchange | Denmark Country |
| Market Cap: | $918,690,000 | Small Cap (Between $200M and $2B) |
| Analyst Recommendation: | 2.3 | Analysts say: Buy-. (1=Strong Buy, 5=Strong Sell) |
| Beta: | N/A | Unknown Beta. A beta of 1 means that stock will go up or down at the same rate as the S&P 500 index. |
ForwardPE: Unknown | 5 Yr Est Growth: 21.00% | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: -18.77% | % Above 200 DayMA: -12.43% |
FWP Performance 52 Weeks: -12.52% | S&P 500 Performance 52 Weeks: 13.50% |
Downtrend is still intact: FWP is below both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week Low than 52 Week High. | FWP underperforming S&P 500 by -26.02% the last 52 Weeks. |
Price To Book: 5.9 | OK Value. Low Price to Book means better value. A P/B value of 5 or less is great. |
EV to EBITDA: -14.12 | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | N/A | 17.28% | Unknown. |
| % Held By Institutions | N/A | 62.07% | Unknown. |
| Short % Of Float | N/A | 07.02% | Unknown. |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | N/A | -05.28% | Unknown. |
| Return on Equity % | -20.05% | -08.79% | Return on Equity less than average percent. Stock can do better than this? |
| Return on Assets % | -20.02% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
| Revenue Per Employee | $N/A | $883,096.70 | Unknown. |
| Price to Cash | 6.71 | 5.52 | Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|